206640.KQ
Boditech Med Inc.
KOE · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 8,560.00
+0.71%Year over year
Reported trailing growth
- Revenue
- +16.9%
- EBITDA
- -48.8%
- EBIT
- -5.5%
- EPS
- +4.7%
- Free cash flow
- —
- Operating cash flow
- -41.2%
Forward estimates
Based on analyst estimates
- Revenue
- +9.6%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +11.1%
- EBITDA
- +3.0%
- EBIT
- +7.5%
- Net income
- -0.7%
- EPS
- +0.4%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026